Teleflex Incorporated (TFX) - What Are Researchers Thinking About This Stock?

Key Points

• Analysts rate Teleflex a “Moderate Buy”, with five buy ratings, one strong-buy, five hold ratings and one sell rating. The average 12-month price target is $154.40.
• Teleflex exceeded quarterly expectations, reporting EPS of $1.76 versus the $1.28 consensus and revenue of $570.33 million, up 28.9% year over year. Analysts project full-year EPS of $7.22.
• The company pays a quarterly dividend of $0.34 per share, equivalent to a 1.0% yield, while institutional investors own approximately 95.62% of outstanding shares.

Teleflex Incorporated (NYSE:TFX - Get Free Report) has been assigned an average rating of "Moderate Buy" from the twelve research firms that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, five have assigned a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $154.40.

Several equities research analysts recently issued reports on the stock. Wall Street Zen raised shares of Teleflex from a "sell" rating to a "hold" rating in a report on Sunday, August 9th. Zacks Research cut shares of Teleflex from a "strong-buy" rating to a "hold" rating in a research note on Friday, October 23rd. UBS Group lifted their price target on shares of Teleflex from $145.00 to $158.00 and gave the company a "neutral" rating in a report on Tuesday, August 11th. Truist Financial dropped their price target on shares of Teleflex from $150.00 to $142.00 and set a "hold" rating for the company in a research report on Wednesday, October 14th. Finally, Mizuho increased their price objective on shares of Teleflex from $140.00 to $145.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 15th.

Teleflex Stock Down 1.1%

TFX opened at $139.89 on Friday. The company has a current ratio of 2.60, a quick ratio of 2.12 and a debt-to-equity ratio of 0.94. Teleflex has a 1-year low of $100.18 and a 1-year high of $145.00. The company has a market capitalization of $5.93 billion, a PE ratio of -6.01, a PEG ratio of 0.95 and a beta of 0.83. The firm's 50 day simple moving average is $131.36 and its two-hundred day simple moving average is $125.00.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.28 by $0.48. The firm had revenue of $570.33 million during the quarter, compared to the consensus estimate of $559.59 million. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The company's revenue for the quarter was up 28.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. As a group, equities analysts forecast that Teleflex will post 7.22 EPS for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Friday, August 14th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend was Friday, August 14th. Teleflex's dividend payout ratio (DPR) is presently -5.84%.

Institutional Investors Weigh In On Teleflex

A number of hedge funds have recently bought and sold shares of the business. Diamond Hill Capital Management LLC Investment Advisor bought a new position in Teleflex during the second quarter valued at $39,467,000. Fifth Third Bancorp lifted its holdings in shares of Teleflex by 3,204.8% in the 1st quarter. Fifth Third Bancorp now owns 68,144 shares of the medical technology company's stock worth $8,151,000 after acquiring an additional 66,082 shares during the last quarter. Assenagon Asset Management S.A. bought a new stake in shares of Teleflex in the 2nd quarter worth about $1,391,000. Irenic Capital Management LP bought a new stake in shares of Teleflex in the 1st quarter worth about $104,061,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Teleflex during the 2nd quarter worth about $1,065,000. Hedge funds and other institutional investors own 95.62% of the company's stock.

Teleflex Company Profile

Teleflex Incorporated is a global medical technology company that develops, manufactures and markets specialty medical devices. Its products are designed to support healthcare professionals in critical care and procedural settings, including vascular access, interventional cardiology and radiology, anesthesia, respiratory care, emergency medicine, surgical applications and urology.

The company's portfolio includes catheters, access and closure devices, airway-management products, surgical instruments, pain-management devices and other technologies used in hospitals and outpatient facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.